173 related articles for article (PubMed ID: 11917194)
1. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
3. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
4. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
Ford ES; Cooper RS; Simmons B; Castaner A
J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
7. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
8. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
Shima K; Tanaka A; Ejiri N; Maezawa H
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
[TBL] [Abstract][Full Text] [Related]
11. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
12. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
Meyer E; Westerveld HT; de Ruyter-Meijstek FC; van Greevenbroek MM; Rienks R; van Rijn HJ; Erkelens DW; de Bruin TW
Atherosclerosis; 1996 Aug; 124(2):221-35. PubMed ID: 8830935
[TBL] [Abstract][Full Text] [Related]
13. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
14. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
[TBL] [Abstract][Full Text] [Related]
15. [Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease].
Chemnitius JM; Winkel H; Meyer I; Schirrmacher K; Armstrong VW; Kreuzer H; Zech R
Med Klin (Munich); 1998 Mar; 93(3):137-45. PubMed ID: 9564161
[TBL] [Abstract][Full Text] [Related]
16. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
[TBL] [Abstract][Full Text] [Related]
17. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
Saha N; Roy AC; Teo SH; Tay JS; Ratnam SS
Clin Genet; 1991 Oct; 40(4):277-82. PubMed ID: 1661643
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
[TBL] [Abstract][Full Text] [Related]
19. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
